Normal view
MARC view
Innovation and Marketing in the Pharmaceutical Industry (Record no. 399220)
[ view plain ]
| 000 -Маркер записи | |
|---|---|
| Контрольное поле постоянной длины | 05636nam a22005055i 4500 |
| 001 - Контрольный номер | |
| Контрольное поле | vtls000540898 |
| 005 - Дата корректировки | |
| Контрольное поле | 20210922082053.0 |
| 007 - Кодируемые данные (физ. описан.) | |
| Контрольное поле постоянной длины | cr nn 008mamaa |
| 008 - Кодируемые данные | |
| Контрольное поле постоянной длины | 160915s2014 xxu| s |||| 0|eng d |
| 020 ## - Индекс ISBN | |
| ISBN | 9781461478010 |
| -- | 978-1-4614-7801-0 |
| 024 7# - Прочие стандартные номера | |
| Стандартный номер | 10.1007/978-1-4614-7801-0 |
| Источник номера | doi |
| 035 ## - Системный контрольный номер | |
| Системный контрольный номер | to000540898 |
| 040 ## - Источник каталогиз. | |
| Служба первич. каталог. | Springer |
| Служба, преобразующая запись | Springer |
| Организация, изменившая запись | RU-ToGU |
| 050 #4 - Расстановочный код библ. Конгресса | |
| Классификационный индекс | HB71-74 |
| 072 #7 - Код предметной/темат. категории | |
| Код предметной/темат. категории | K |
| Источник кода | bicssc |
| 072 #7 - Код предметной/темат. категории | |
| Код предметной/темат. категории | BUS000000 |
| Источник кода | bisacsh |
| 082 04 - Индекс Дьюи | |
| Индекс Дьюи | 330 |
| Номер издания | 23 |
| 245 10 - Заглавие | |
| Заглавие | Innovation and Marketing in the Pharmaceutical Industry |
| Физический носитель | electronic resource |
| Продолж. заглавия | Emerging Practices, Research, and Policies / |
| Ответственность | edited by Min Ding, Jehoshua Eliashberg, Stefan Stremersch. |
| 260 ## - Выходные данные | |
| Место издания | New York, NY : |
| Издательство | Springer New York : |
| -- | Imprint: Springer, |
| Дата издания | 2014. |
| 300 ## - Физическое описание | |
| Объем | VII, 768 p. 111 illus., 95 illus. in color. |
| Иллюстрации/тип воспроизводства | online resource. |
| 336 ## - Тип содержимого | |
| Тип содержимого | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - Средство доступа | |
| Средство доступа | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - Тип носителя | |
| Тип носителя | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 490 1# - Серия | |
| Заглавие серии | International Series in Quantitative Marketing, |
| ISSN серии | 0923-6716 ; |
| № тома | 20 |
| 505 0# - Примечание о содержании | |
| Содержание | Chapter 1 The Pharmaceutical Industry: Specificity, Challenges and What You Can Learn from this Book -- Chapter 2 Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development -- Chapter 3 Portfolio Management in New Drug Development -- Chapter 4 Grassroots Innovation: A Promising Innovation Paradigm for Pharmaceutical Companies -- Chapter 5 New Challenges in Alliance Portfolio Management -- Chapter 6 Evaluating the Impact of Treatment Effectiveness and Side Effects in Prescribing Choices -- Chapter 7 The Successful Launch and Diffusion of New Therapies -- Chapter 8 Pharmaceutical Lifecycle Extension Strategies -- Chapter 9 Patent Expiry and Pharmaceutical Market Opportunities at the Nexus of Pricing and Innovation Policy -- Chapter 10 Risk Assessment: The Consumer as an Intuitive Statistician -- Chapter 11 Efficacy Expectations and Adherence: Evidence of Consumer Biases and Heuristics in Pharmaceutical Marketing -- Chapter 12 Factors Affecting Adherence to Governmental Health Warnings and the Case of Over-the-Counter Cough and Cold Medications (OTC-CCM) in Children Under Two -- Chapter 13 Vaccine Marketing -- Chapter 14 Patient Empowerment: Consequences for Pharmaceutical Marketing and for the Patient-Physician Relationship -- Chapter 15 Leveraging Peer-to-Peer Networks in Pharmaceutical Marketing -- Chapter 16 Leveraging Social Media in the Pharmaceutical Industry -- Chapter 17 Understanding Sample Usage and Sampling as a Promotion Tool: State of Industry Practice and Current Research -- Chapter 18 Pharmaceutical Detailing Elasticities: A Meta-Analysis -- Chapter 19 Marketing Spending Models -- Chapter 20 Modeling the Effects of Promotional Efforts on Pharmaceutical Demand: What We Know and Challenges for the Future -- Chapter 21 Direct-to-Consumer Advertising of Pharmaceuticals: An Integrative Review -- Chapter 22 How DTCA Influences Prescription Pharmaceutical Markets -- Chapter 23 Spillovers and Other Externalities in Pharmaceutical Marketing -- Chapter 24 Closing the Marketing Strategy-Tactics Gap: An Institutional Theory Analysis of Pharmaceutical Value Chain. |
| 520 ## - Аннотация | |
| Аннотация | The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike. . |
| 650 #0 - Тематические рубрики | |
| Основная рубрика | Economics. |
| 9 (RLIN) | 135154 |
| 650 #0 - Тематические рубрики | |
| Основная рубрика | Pharmaceutical technology. |
| 9 (RLIN) | 410704 |
| 650 14 - Тематические рубрики | |
| Основная рубрика | Economics/Management Science. |
| 9 (RLIN) | 247365 |
| 650 24 - Тематические рубрики | |
| Основная рубрика | Economics/Management Science, general. |
| 9 (RLIN) | 304660 |
| 650 24 - Тематические рубрики | |
| Основная рубрика | Pharmaceutical Sciences/Technology. |
| 9 (RLIN) | 329108 |
| 650 24 - Тематические рубрики | |
| Основная рубрика | R & D/Technology Policy. |
| 9 (RLIN) | 303704 |
| 650 24 - Тематические рубрики | |
| Основная рубрика | Finance/Investment/Banking. |
| 9 (RLIN) | 416068 |
| 700 1# - Другие авторы | |
| Другие авторы | Ding, Min. |
| Роль лиц | editor. |
| 9 (RLIN) | 446720 |
| 700 1# - Другие авторы | |
| Другие авторы | Eliashberg, Jehoshua. |
| Роль лиц | editor. |
| 9 (RLIN) | 308480 |
| 700 1# - Другие авторы | |
| Другие авторы | Stremersch, Stefan. |
| Роль лиц | editor. |
| 9 (RLIN) | 446721 |
| 710 2# - Другие организации | |
| Организация/юрисдикция | SpringerLink (Online service) |
| 9 (RLIN) | 143950 |
| 773 0# - Источник информации | |
| Название источника | Springer eBooks |
| 830 #0 - Заголовок добавочной библ.записи на серию — унифицированное заглавие | |
| Унифицированное заглавие | International Series in Quantitative Marketing, |
| 9 (RLIN) | 308481 |
| 856 40 - Электронный адрес документа | |
| URL | <a href="http://dx.doi.org/10.1007/978-1-4614-7801-0">http://dx.doi.org/10.1007/978-1-4614-7801-0</a> |
| 912 ## - Coursera for Campus: онлайн курсы для ТГУ | |
| Coursera for Campus: онлайн курсы для ТГУ | ZDB-2-SBE |
| 999 ## - Системные контрольные номера (Koha) | |
| biblionumber (Koha) | 399220 |
No items available.